- Home
- MOGO vs PYPD Comparison
MOGO vs PYPD Comparison
Compare MOGO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGO
- PYPD
- Stock Information
- Founded
- MOGO 2003
- PYPD 2008
- Country
- MOGO Canada
- PYPD Israel
- Employees
- MOGO N/A
- PYPD N/A
- Industry
- MOGO
- PYPD Medical/Dental Instruments
- Sector
- MOGO
- PYPD Health Care
- Exchange
- MOGO Nasdaq
- PYPD Nasdaq
- Market Cap
- MOGO 25.1M
- PYPD 25.0M
- IPO Year
- MOGO N/A
- PYPD 2020
- Fundamental
- Price
- MOGO $1.04
- PYPD $2.75
- Analyst Decision
- MOGO Strong Buy
- PYPD Strong Buy
- Analyst Count
- MOGO 1
- PYPD 2
- Target Price
- MOGO $4.00
- PYPD $10.50
- AVG Volume (30 Days)
- MOGO 59.3K
- PYPD 10.5K
- Earning Date
- MOGO 05-08-2025
- PYPD 05-07-2025
- Dividend Yield
- MOGO N/A
- PYPD N/A
- EPS Growth
- MOGO N/A
- PYPD N/A
- EPS
- MOGO N/A
- PYPD N/A
- Revenue
- MOGO $29,244,391.00
- PYPD N/A
- Revenue This Year
- MOGO $78.36
- PYPD N/A
- Revenue Next Year
- MOGO N/A
- PYPD N/A
- P/E Ratio
- MOGO N/A
- PYPD N/A
- Revenue Growth
- MOGO 1.46
- PYPD N/A
- 52 Week Low
- MOGO $0.74
- PYPD $2.30
- 52 Week High
- MOGO $1.95
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- MOGO 60.82
- PYPD 52.19
- Support Level
- MOGO $0.80
- PYPD $2.65
- Resistance Level
- MOGO $0.85
- PYPD $2.76
- Average True Range (ATR)
- MOGO 0.08
- PYPD 0.11
- MACD
- MOGO 0.02
- PYPD 0.03
- Stochastic Oscillator
- MOGO 88.26
- PYPD 93.75
About MOGO Mogo Inc.
Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.